cell & molecular biology, inflammation, cancer

NSAIDs reduce this "parainflammation," hinting at how they help lower cancer risk.

Obese people are at higher risk for developing cancer, have worse prognoses once diagnosed, and are often resistant to chemotherapy regimens. The question is, Why?

A roundup of recent research announced this week at the annual conference of the American Association for Cancer Research (AACR).

Early experiments show that a hybrid form of the common pain reliever can effectively inhibit the growth of many tumor types.

Recent clinical trials have reignited the interest in simple anti-inflammatory drugs like aspirin for controlling the inflammation associated with cancer. 

Can tumors—which can originate from, and often resemble, chronically inflamed tissue—be curtailed using familiar anti-inflammatory agents, without their side effects?